13 electric-machine-design-"https:"-"https:"-"https:" Fellowship positions at King's College London
-
“participation”, and will consider candidates with a PhD in a variety of fields, including experimental and quantitative social sciences, human-computer interaction (HCI), design research, experimental psychology
-
the design of smarter diagnostics and effective treatments. The team aim to understand the fundamental biological processes involved in dementia at a molecular level – and to use that knowledge
-
applications, addressing cancer’s social determinants, lowering barriers to UK SMEs, catalysing innovation and positioning the UK as a global leader in this dynamic ecosystem. PharosAI is a joint venture between
-
into Professor Sheeba Irshad and will be based at Guy’s Cancer Centre in London Bridge. This post offers hands-on experience in translational trial design, clinical delivery, and immuno-oncology research
-
the design of smarter diagnostics and effective treatments. The team aim to understand the fundamental biological processes involved in dementia at a molecular level – and to use that knowledge
-
knowledge of research methods and study design in clinical trials/experimental/psychopharmacology. Downloading a copy of our Job Description Full details of the role and the skills, knowledge and experience
-
adoption of innovations through modern trial design, integrated delivery infrastructure, portfolio governance, and partnerships across industry, academia and the NHS. The post is based in the Department
-
platform that accelerates the evaluation and adoption of innovations through modern trial design, integrated delivery infrastructure, portfolio governance, and partnerships across industry, academia and the
-
an exceptional Computer Scientist, Computational Biologist, AI Researcher, or Data Scientist to join a pioneering interdisciplinary programme that aims to revolutionise our understanding of human physiology and
-
platform that accelerates the evaluation and adoption of innovations through modern trial design, integrated delivery infrastructure, portfolio governance, and partnerships across industry, academia and the